Bacterial profile and patterns of antimicrobial drug resistance in intra-abdominal infections: Current experience in a teaching hospital

Indian Journal of Pathology and Microbiology

Volumn 56, Issue 4, 2013, Pages 388-392

  Shree, Neetu ^a   Arora, Balvinder S ^a   Mohil, Ravinder S ^a   Kasana, Dimple ^a   Biswal, Indu ^a  

^a SAFDARJUNG HOSPITAL   (India)

Author keywords

Antibiotic resistance; ESBL; gram negative bacilli; intra abdominal infections.

Indexed keywords

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HOSPITALS, TEACHING; HUMANS; INTRAABDOMINAL INFECTIONS; MICROBIAL SENSITIVITY TESTS;

EID: 84893982174     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.125321     Document Type: Article

References (28)

1. Agarwal N, Saha S, Srivastava A, Chumber S, Dhar A, Garg S. Peritonitis: 10 years' experience in a single surgical unit. Trop Gastroenterol 2007;28:117-20.
2. Hawser SP, Badal RE, Bouchillon SK, Hoban DJ; SMART India Working Group. Antibiotic Susceptibility of Intra Abdominal Infection isolates from Indian Hospitals during 2008. J Med Microbiol 2010;59:1050-4.
3. Collee JG, Miles RS, Watt B. Mackie and McCartney Practical Medical Microbiology. Collee JG, Fraser AG, Marmion BP, Simmons A. Tests for identification of bacteria. 14th ed. USA: 1996; Elsevier. p. 131-49.
4. Somer HR, Summanen P, Citron DM, Baron EJ, Wexler HM, Finegold SM. Wadsworth-KTL Anaerobic bacteriology Manual. 6th ed. Belmont, California 2002; Star.
5. Clinical Laboratory Standards Institute; Performance standards for antimicrobial susceptibility testing. 20th Informational Supplement: 2010.
6. Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, et al. In vitro susceptibilities of aerobic and facultative Gramnegative bacilli isolated from patients with intra-Abdominal infections worldwide: 2004 Study for monitoring antimicrobial resistance trends (SMART). J Antimicrob Chemother 2006;58:205-10.
7. Chen YH, Hsueh PR, Badal RE, Hawser SP, Hoban DJ, Bouchillon SK, et al. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-Abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect 2011;62:280-91.
8. Sepehri G, Nejad HZ, Sepehri E, Razban S. Bacterial profile and antimicrobial resistance to commonly used antimicrobials in intraabdominal infections in two Teaching Hospitals. Am J Applied Sci 2010;7:38-43.
9. Villegas MV, Blanco MG, Sifuentes-Osornio J, Rossi F. Increasing prevalence of extended-spectrum-beta lactamase among gram-negativebacilli in latin america-2008 update from the study for monitoring antimicrobial resistance trends (smart). Braz J Infect Dis 2011;15:34-9.
10. Hauser SP, Bouchillon SK, Hoban DJ, Badal RE, Hsueh PR, Paterson DL. Emergence of high levels of ESBL producing gram negative bacilli in the asia pacific region: Data from the study for monitoring antimicrobial resistance trends(SMART) programme, 2007. Antimicrob Agents Chemother 2009;53:3280-4.
11. Agrawal P, Ghosh AN, Kumar S, Basu B, Kapila K. Prevalence of extendedspectrum-beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolates in a tertiary care hospital. Indian J Pathol Microbiol 2008;51:139-42.
12. Sinha P, Sharma R, Rishi S, Sharma R, Sood S, Pathak D. Prevalence of extended spectrum beta-lactamases and AmpC beta-lactamase producers among Escherichia coli isolates in a tertiary care hospital in Jaipur. Indian J Pathol Microbiol 2008;51:367-9.
13. Goldstein EJ, Syndman DR. Intra-Abdominal infections: Review of the bacteriology, antimicrobial susceptibility and the role of etrapenam in their therapy. J Antimicrob Chemother 2004;53:29-36.
14. Paterson DL, Rossi F, Baquero F, Hsuehand PR, Woods GL, Satishchandran V, et al. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-Abdominal infections worldwide: The 2003 Study for monitoring antimicrobial resistance trends (SMART). J Antimicrob Chemother 2005;55:965-73.
15. Chaudhuri BN, Rodrigues C, Balaji V, Iyer R, Sekar U, Wattal C, et al. Incidence of ESBL producers amongst Gram-negative bacilli isolated from intra-Abdominal infections across India (based on SMART study, 2007 data). J Assoc Physicians India 2011;59:287-92.
16. Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E. The efficacy and safety of tigecycline for the treatment of complicated abdominal infections: Analysis of pooled clinical trial data. Clin Infect Dis 2005;41 Suppl 5:S354-67.
17. Bradford PA, Weaver-Sands DT, Patersen PJ. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infection and complicated abdominal infections. Clin Infect Dis 2005;41 Suppl 5:S315-32.
18. Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant gram-negative bacteria. Int J Antimicrob Agents 2005;25:11-25.
19. Stein A, Raoult D. Colistin: An antimicrobial for the 21st century?. Clin Infect Dis 2002;35:901-2.
20. Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, et al. Clinical and microbiological profiles of community acquired and nosocomial intra-Abdominal infections: Result of the french prospective, observational EBIIA study. J Antimicrob Chemother 2009;63:785-94.
21. Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of pseudomonas aeruginosa infections. Drugs 2007;67:351-68.
22. Obritsch MD, Fish DN, MacLaren R, Jung R. Nosocomial infections due to multi-drug resistant pseudomonas aeruginosa: Epidemiology and treatment options. Pharmacotherapy 2005;25:1353-64.
23. Brook I. Microboilogy and management of peritonsillar, retropharyngeal and parapharyngeal abscesses. J Oral MaxillofacSurg 2004;62:1545-50.
24. Meher R, Jain A, Sabharwal A, Gupta B, Singh I, Agarwal AK. Deep neck abscess: A prospective study of 54 cases. J Laryngol Otol 2005;119:299-302.
25. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community-And health-care associated methicillin resistant Staphylococcus aureus infection. JAMA 2003;290:2976-84.
26. Burnett RJ, Haverstock DC, Dellinger EP, Reinhart HH, Bohnen JM, Rotstein OD, et al. Definition of the role of enterococcus in intraabdominal infection: Analysis of a prospective randomized trial. Surgery 1995;118:716-21.
27. Sood S, Malhotra M, Das BK, Kapil A. Enterococcal infections & antimicrobial resistance. Indian J Med Res 2008;128:111-21.
28. Lee Y, Park Y, Kim MS, Yong D, Jeong SH, Lee K, et al. Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea. Antimicrob Agents Chemother 2010;54:3993-7.